drugset / Trial / NCT02369406

Summary

The overall objective of this study is to determine whether very early antiretroviral treatment (ART) initiation in HIV-infected infants limits the seeding of viral reservoirs and maintains immune responses, potentially allowing future periods off ART.

Timeline

Start
2015-05-04
Primary completion
2020-11-06
Completion
2029-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Kaletra Unknown — —
Subject Lamivudine Other / unclassified — —
Subject Nevirapine Small molecule 6 mg/kg —
Subject Zidovudine Small molecule — —

Indications